Komori
Medix (331A) · InitiativeAdvanced

Strengthening Corporate Governance and Internal Control Systems

First written in FY2025. 1 of 2 entries say "Advanced", first in FY2026. Latest entry: FY2026.

2entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY20252025: 120252026: 12026
Same theme, other companies
Continuous Strengthening of Corporate Governance and Internal Control SystemsA theme 993 companies write about · 4 as a headwind · 1093 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 185 companies compared. The sentences above are computed from all 185.Comparing 200 of the theme's 1099 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「We have established an Internal Audit Office directly reporting to the President, staffed by 3 people. The Internal Audit Office conducts operational audits to determine whether our business activities are being conducted appropriately and effectively in compliance with laws, regulations and internal rules, and provides guidance and advice.」

    The company has established specific governance and internal control arrangements, including a 3-person Internal Audit Office directly reporting to the President, a Risk and Compliance Committee, and a subsidiary management framework.
  2. FY2025First statedAnnual report

    「In accordance with the basic principles of the Corporate Governance Code, we regard meeting the trust placed in us by all stakeholders, including shareholders, as a fundamental corporate mission. We are working to strengthen our compliance framework, enhance the speed and accuracy of information disclosure, and reinforce corporate governance. As part of these efforts, in March 2023 we transitioned to a company with an Audit and Supervisory Committee, strengthened the Board of Directors’ supervisory function by adding outside directors to its membership, and are achieving highly transparent management through auditing and supervision of the legality and appropriateness of business execution.」

    The company combines the transition to a company with an Audit and Supervisory Committee, the appointment of outside directors, and stronger compliance and information disclosure.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Medix's next results are scheduled for 2026-11-10. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.